Passa al contenuto
Merck
Tutte le immagini(2)

Documenti fondamentali

SRP0123

Sigma-Aldrich

JMJD2C Active human

recombinant, expressed in baculovirus infected insect cells, ≥80% (SDS-PAGE)

Sinonimo/i:

GASC1, Gene amplified in squamous cell carcinoma 1 protein, JHDM3C, KIAA0780, Lysine-specific demethylase 4C (KDM4C)

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali


About This Item

Codice UNSPSC:
12352200

Origine biologica

human

Ricombinante

expressed in baculovirus infected insect cells

Saggio

≥80% (SDS-PAGE)

Stato

aqueous solution

PM

69 kDa

Confezionamento

pkg of 100 μg

Concentrazione

>0.02 mg/mL

N° accesso NCBI

N° accesso UniProt

Condizioni di spedizione

dry ice

Temperatura di conservazione

−70°C

Informazioni sul gene

human ... KDM4C(23081)

Descrizione generale

JMJD2C (Jumonji domain containing), also known as KDM4C (lysine demethylase 4C), is an H3K9me3 demethylase belonging to the conserved family of H3K9me3 erasers, KDM4 demethylases. KDM4 family was first identified in 2006, and is composed of six members namely KDM4A, -B, -C, -D, -E, and -F. This protein predominantly resides at H3K4me3-containing promoter region. JMJD2C protein has multiple reader domains, including a hybrid tandem tudor domain (TTD) and two PHDs (plant homeodomain) of unknown function.[1][2]
Human JMJD2C, GenBank Accession No. BC143571) (amino-acids 2-372) with N-terminal ST tag, MW = 69kDa, expressed in a Baculovirus infected Sf9 cell expression system.

Applicazioni

Useful for the study of enzyme kinetics, screening inhibitors, and selectivity profiling.

Azioni biochim/fisiol

JMJD2C (Jumonji domain containing), also known as KDM4C (lysine demethylase 4C), is a type of KDM4 demethylases that are responsible for the demethylation of H3K9me2/3, H3K36me3/2, and H1.4K26me3/2. This is accomplished through a hydroxylation reaction requiring the cofactors Fe(II) and 2-oxoglutarate (2-OG). These proteins show heightened expression and activity in multiple types of cancers, and hence, are also classified as oncogenes. KDMA4 family members are capable of coregulating hormone receptors, and hence, are implicated in the progression of hormone dependent cancers, such as breast and prostate cancer.[2] JMJD2C is essential for regulating the expression of growth promoting proteins and the survival factor FRA1 (Fos-related antigen 1) and cyclin D1, and BCL2 (B-cell lymphoma) respectively. The expression of JMJD2C is increased in colon cancer cell, where it interacts with the oncogenic protein β-catenin, the up-regulation of which is essential for the pathogenesis of colon cancer.[3]

Definizione di unità

One unit is defined as the amount of enzyme required to demethylate 1 pmol of substrate/min at 37°C.

Stato fisico

Formulated in 25 mM Tris-HCl, pH 8.0, 100 mM NaCl, 0.05% Tween-20, 20% glycerol and 3 mM DTT.

Nota sulla preparazione

Thaw on ice. Upon first thaw, briefly spin tube containing enzyme to recover full content of the tube. Aliquot enzyme into single use aliquots. Store remaining undiluted enzyme in aliquots at -70°C. Note: Enzyme is very sensitive to freeze/thaw cycles.

Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

Non trovi la versione di tuo interesse?

Se hai bisogno di una versione specifica, puoi cercare il certificato tramite il numero di lotto.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

Lindsey R Pack et al.
The Journal of biological chemistry, 291(12), 6060-6070 (2016-01-10)
Histone H3 lysine 4 trimethylation (H3K4me3) and histone H3 lysine 9 trimethylation (H3K9me3) are epigenetic marks with opposing roles in transcription regulation. Whereas colocalization of these modifications is generally excluded in the genome, how this preclusion is established remains poorly
Pro-growth role of the JMJD2C histone demethylase in HCT-116 colon cancer cells and identification of curcuminoids as JMJD2 inhibitors.
Kim TD et al
American Journal of Translational Research, 6(3), 236-247 (2014)
Ulrike Leurs et al.
ACS chemical biology, 9(9), 2131-2138 (2014-07-12)
Inhibition of histone demethylases has within recent years advanced into a new strategy for treating cancer and other diseases. Targeting specific histone demethylases can be challenging, as the active sites of KDM1A-B and KDM4A-D histone demethylases are highly conserved. Most

Domande

Recensioni

Nessuna valutazione

Filtri attivi

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.